Health Catalyst Inc
F:2YP

Watchlist Manager
Health Catalyst Inc Logo
Health Catalyst Inc
F:2YP
Watchlist
Price: 1.14 EUR -8.8% Market Closed
Market Cap: €67.3m

Health Catalyst Inc
Investor Relations

Health Catalyst makes software and services that help hospitals and health systems organize clinical and financial data, analyze performance, and improve care delivery. Its products pull data from many hospital systems into one place, then turn it into dashboards, reports, and decision support tools that managers and clinicians use to spot inefficiencies, track outcomes, and manage costs. The company mainly sells subscription software, implementation work, and consulting services to healthcare providers, including large hospital networks and related organizations. Customers pay Health Catalyst to install and maintain the platform, connect data sources, and help staff use the tools to make better operating and clinical decisions. What makes the business different is that it sits between raw hospital data and day-to-day operations. It does not just sell generic software; it focuses on the messy, highly regulated healthcare environment, where customers need a system that can handle many data sources and translate them into practical actions for care teams, finance groups, and administrators.

Show more
Loading...
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q1 2026
Call Date
May 11, 2026
AI Summary
Q1 2026

Beat and raise: Health Catalyst beat Q1 expectations on revenue and adjusted EBITDA, then issued full-year 2026 guidance for revenue of $260 million to $265 million and adjusted EBITDA of $30 million to $33 million.

Migration pressure: Management said the DOS-to-Ignite migration strategy has created churn and revenue pressure, but they now have a client-by-client plan and expect most of the impact to be absorbed in 2026.

Cost reset: The company launched Project Nexus, a restructuring expected to generate about $30 million of annual run-rate savings, with most of the charges hitting in Q2.

AI push: Leadership positioned AI as a major future growth driver, saying the company’s proprietary improvement data and new AI agents are the core of its moat.

Bookings strength: Q1 bookings were described as strong, with management expecting moderate Q2 bookings and positive momentum in the second half of the year.

Key Financials
Revenue
$70.8 million
Technology revenue
$49.5 million
Professional services revenue
$21.3 million
Adjusted gross margin
51.5%
Adjusted technology gross margin
55.3%
Adjusted professional services gross margin
19.4%
Adjusted operating expenses
$27.3 million
Adjusted EBITDA
$9.1 million
Adjusted net income per share
$0.02
Cash, cash equivalents and short-term investments
$108.8 million
Restructuring charges
approximately $4 million
Annual run-rate savings
approximately $30 million
Headcount reduction
9% reduction in head count
Direct savings
approximately $22 million
Indirect savings
approximately $8 million
Quarterly adjusted operating expenses change
$3 million to $4 million decrease
Quarterly adjusted cost of revenue change
$1 million to $2 million decrease
Potentially at-risk ARR
approximately $52 million
Retained at-risk ARR
at least $22 million
Remaining at-risk ARR
approximately $30 million
Expected services revenue exiting 2026
between $55 million and $65 million
New bookings
$22 million to $26 million
Other Earnings Calls

Management

Mr. Daniel D. Burton
CEO & Director
No Bio Available
Mr. Jason Alger
Chief Financial Officer
No Bio Available
Mr. Benjamin Landry
General Counsel & Secretary of the Board
No Bio Available
Ms. Linda Llewelyn
Chief People Officer
No Bio Available
Mr. Daniel LeSueur
Chief Operating Officer
No Bio Available
Mr. Dave Ross
Chief Technology Officer
No Bio Available
Mr. Adam Brown
Senior Vice President of Investor Relations and Financial Planning & Analysis
No Bio Available
Ms. Amanda Flanders
Senior Vice President of Marketing & Communications
No Bio Available
Mr. Kyle J. Salyers
Chief Strategy Officer & Senior VP of Corporate Development
No Bio Available
Mr. Jeffrey P. Selander
Senior Vice President of International
No Bio Available

Contacts

Address
UTAH
South Jordan
10897 South River Front Parkway, #300
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett